Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
May 22  •  04:00PM ET
116.78
Dollar change
+0.21
Percentage change
0.18
%
Index
-
P/E
15.79
EPS (ttm)
7.40
Insider Own
0.73%
Shs Outstand
76.36M
Perf Week
0.34%
Market Cap
8.92B
Forward P/E
9.67
EPS next Y
12.07
Insider Trans
0.00%
Shs Float
75.65M
Perf Month
9.82%
Enterprise Value
12.02B
PEG
38.69
EPS next Q
2.72
Inst Own
105.97%
Perf Quarter
11.58%
Income
599.48M
P/S
1.10
EPS this Y
-13.15%
Inst Trans
2.56%
Perf Half Y
-26.47%
Sales
8.10B
P/B
0.96
EPS next Y
7.16%
ROA
3.56%
Perf YTD
-35.91%
Book/sh
122.25
P/C
19.02
EPS next 5Y
0.25%
ROE
6.27%
52W High
211.00 -44.65%
Perf Year
-8.04%
Cash/sh
6.14
P/FCF
9.18
EPS past 3/5Y
61.03% 6.54%
ROIC
4.86%
52W Low
66.57 75.42%
Perf 3Y
-45.91%
Dividend Est.
-
EV/EBITDA
7.41
Sales past 3/5Y
14.75% 24.17%
Gross Margin
23.27%
Volatility
5.06% 5.58%
Perf 5Y
-49.46%
Dividend TTM
-
EV/Sales
1.48
EPS Y/Y TTM
-17.89%
Oper. Margin
13.99%
ATR (14)
6.08
Perf 10Y
78.02%
Dividend Ex-Date
-
Quick Ratio
1.06
Sales Y/Y TTM
-2.46%
Profit Margin
7.40%
RSI (14)
52.15
Dividend Gr. 3/5Y
- -
Current Ratio
1.06
EPS Q/Q
-98.72%
SMA20
0.35%
Beta
1.22
Payout
-
Debt/Eq
0.38
Sales Q/Q
0.63%
SMA50
5.49%
Rel Volume
0.33
Prev Close
116.57
Employees
-
LT Debt/Eq
0.32
SMA200
-23.43%
Avg Volume
1.15M
Price
116.78
IPO
May 15, 1998
Option/Short
Yes / Yes
Trades
Volume
383,732
Change
0.18%
Date Action Analyst Rating Change Price Target Change
May-18-26Resumed RBC Capital Mkts Sector Perform $123
Mar-26-26Upgrade BMO Capital Markets Market Perform → Outperform $130
Feb-23-26Upgrade Jefferies Hold → Buy $135
Feb-18-26Upgrade TD Cowen Hold → Buy $120
Feb-17-26Downgrade Rothschild & Co Redburn Buy → Neutral $100
Feb-12-26Downgrade Leerink Partners Outperform → Market Perform $105
Feb-12-26Downgrade BofA Securities Neutral → Underperform $75
Jan-08-26Downgrade Truist Buy → Hold $222
Dec-15-25Downgrade BofA Securities Buy → Neutral $195
Nov-13-25Initiated BMO Capital Markets Market Perform $175
May-18-26 09:55AM
May-13-26 08:00AM
Mar-26-26 09:45AM
Mar-24-26 08:00AM
Mar-11-26 06:00AM
09:11AM Loading…
Mar-10-26 09:11AM
Mar-09-26 12:17AM
Mar-05-26 09:56AM
Mar-02-26 12:55AM
Mar-01-26 04:23AM
Feb-26-26 06:45PM
Feb-24-26 02:46PM
Feb-23-26 09:08PM
Feb-18-26 10:10AM
Feb-17-26 09:43AM
08:32AM Loading…
Feb-15-26 08:32AM
Feb-14-26 08:17AM
Feb-13-26 11:25PM
Feb-12-26 04:16PM
02:19PM
11:10AM
10:07AM
09:44AM
07:38AM
Feb-11-26 10:00AM
Feb-05-26 07:23PM
Jan-27-26 07:15AM
Jan-22-26 12:06AM
Jan-05-26 07:27AM
Dec-17-25 08:53AM
10:31AM Loading…
Dec-10-25 10:31AM
Dec-09-25 07:46AM
07:15AM
Dec-02-25 07:15AM
Nov-27-25 11:30AM
Nov-26-25 06:27PM
Nov-25-25 07:46AM
Nov-21-25 11:30AM
Nov-13-25 09:11AM
Nov-12-25 06:45AM
Nov-06-25 07:28PM
Oct-24-25 06:41PM
Oct-23-25 11:15AM
Oct-22-25 05:45PM
04:25PM
Oct-20-25 10:00AM
Oct-15-25 10:00AM
Oct-01-25 06:48PM
Sep-26-25 08:52AM
Sep-14-25 01:17AM
Sep-09-25 12:11PM
Sep-04-25 08:00AM
Sep-02-25 06:00AM
Sep-01-25 12:20PM
Aug-18-25 06:45PM
Aug-12-25 11:41PM
08:54AM
Aug-11-25 07:50AM
Aug-06-25 06:42PM
Jul-25-25 09:45PM
Jul-24-25 06:37PM
Jul-23-25 05:50PM
04:20PM
04:15PM
Jul-17-25 10:00AM
Jul-16-25 10:00AM
07:15AM
Jul-15-25 09:32AM
Jul-07-25 07:15AM
07:06AM
Jul-03-25 10:13AM
Jun-27-25 09:15AM
Jun-23-25 06:30AM
Jun-02-25 10:23AM
04:12AM
May-30-25 11:31AM
May-27-25 08:30AM
May-19-25 04:15PM
May-14-25 07:52AM
May-09-25 03:13AM
May-07-25 12:55PM
07:27AM
May-02-25 09:00PM
03:01AM
02:42AM
May-01-25 06:43PM
09:16AM
Apr-30-25 06:15PM
05:23PM
04:15PM
Apr-29-25 09:12AM
Apr-27-25 04:19PM
Apr-24-25 10:01AM
Apr-23-25 10:01AM
Apr-22-25 07:20AM
Apr-10-25 09:26AM
08:55AM
Apr-09-25 07:10AM
Apr-08-25 06:58AM
Apr-03-25 06:13PM
ICON plc operates as a clinical research organization, which engages in the provision of outsourced development services to the pharmaceutical, biotechnology, and medical device industries. It specializes in the development, management and analysis of programs that support clinical development. It operates through the following geographical segments: Ireland, Rest of Europe, U.S. and Other. The company was founded by John Climax and Ronan Lambe in June 1990 and is headquartered in Dublin, Ireland.
Founder & Independent Non-Executive DirectorDr. John Climax Ph.D.
Chief Financial OfficerMr. Nigel Clerkin A.C.A.
CEO & DirectorMr. Barry Balfe
Chief Accounting OfficerLyons Emer
Chief Information OfficerMr. Thomas N. O'Leary
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BARRY EDWARD BALFEOfficerMar 09 '26Proposed Sale105.132,862300,875Mar 09 05:14 PM
BARRY EDWARD BALFEOfficerMar 04 '26Proposed Sale109.2556661,837Mar 04 04:07 PM
NIGEL CLERKINOfficerNov 03 '25Proposed Sale169.241,473249,289Nov 03 04:23 PM
STEPHEN CUTLEROfficerOct 02 '25Proposed Sale190.1918,9013,594,781Oct 02 04:03 PM
BARRY EDWARD BALFEOfficerAug 08 '25Proposed Sale157.4638159,993Aug 08 04:33 PM
THOMAS NOEL O'LEARYOfficerAug 08 '25Proposed Sale157.461,136178,877Aug 08 04:27 PM